查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514034

全球預測診斷市場

Predictive Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球預測診斷市場預計將達到 53 億美元

全球預測診斷市場預計 2023 年為 26 億美元，預計到 2030 年將達到 53 億美元，2023 年至 2030 年複合年成長率為 10.4%。

美國市場預估為7.353億美元，中國預期複合年成長率為9.7%

預計 2023 年美國預測診斷市場規模將達 7.353 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到8.048億美元，2023-2030年分析期間複合年成長率為9.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 9.3% 和 8.6%。在歐洲，德國的複合年成長率預計約為 8.4%。

全球預測診斷市場－主要趨勢與促進因素總結

預防性醫療保健正在經歷從反應性醫學向預防性醫學的轉變，重點是早期發現和預防，以在健康風險發展為更嚴重的情況之前對其進行管理。這種積極主動的方法包括定期檢查、免疫接種和教育工作，以培養更健康的人口。特別是，預防性檢查已成為現代醫療保健的重要組成部分，提供早期預警並防止嚴重的健康損害。例如，在印度，家庭診斷測試迅速普及，尤其是對於 II 型糖尿病等疾病，早期發現可以預防心臟衰竭等併發症。同樣，早期癌症篩檢，例如子宮頸癌的 HPV 檢測和定期乳癌篩檢，可以顯著提高存活率。這些預防措施不僅可以改善健康狀況，還可以透過最大限度地減少廣泛治療和住院治療的需要來減輕經濟負擔。

技術進步使預防保健更加有效和廣泛。人工智慧 (AI) 和機器學習 (ML) 正在提高診斷準確性，並能夠及早發現心臟病和阿茲海默症疾病。美國食品藥物管理局(FDA) 讚揚了基於人工智慧的診斷工具在識別癌症方面的準確性，強調了它們改善醫療保健服務的潛力，特別是在資源有限的環境中。此外，醫療保健組織擴大透過預測分析來利用大量資料，利用機器學習和高級分析來獲取洞察，從而提高業務效率和患者照護。這種方法有助於疾病預防和管理，透過預測疾病進展和促進早期療育改善患者的治療結果。物聯網 (IoT) 技術透過即時監控患者健康狀況並及時進行醫療干預以防止病情惡化，進一步增強了這一點。

儘管有這些好處，但預測診斷和早期檢測技術的採用在確定需求、向患者宣傳其好處以及確保這些創新的財務和監管支持方面面臨著挑戰​​。為了解決這些障礙，醫療保健組織必須進行徹底的市場研究，建立策略夥伴關係，並投資研發。智慧財產權保護以及將新技術融入現有醫療保健系統對於擴大預防性醫療保健的範圍也至關重要。預測診斷的廣泛採用預示著一場以預防和早期療育為重點的醫療保健革命。這種方法不僅旨在降低醫療保健成本，而且還提高生活品質，並為全球醫療保健系統的彈性未來奠定基礎。

受訪企業範例（共47家）

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN NV

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-7843

Global Predictive Diagnostics Market to Reach US$5.3 Billion by 2030

The global market for Predictive Diagnostics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$735.3 Million While China is Forecast to Grow at 9.7% CAGR

The Predictive Diagnostics market in the U.S. is estimated at US$735.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Predictive Diagnostics Market - Key Trends and Drivers Summarized

Preventive healthcare is experiencing a transformative shift from reactive to proactive medical practices, emphasizing early detection and prevention to manage health risks before they develop into more severe conditions. This proactive approach includes regular screenings, vaccinations, and educational outreach, aimed at fostering a healthier population. Preventive screenings, in particular, have become an integral part of modern healthcare, offering early warnings and preventing serious health outcomes. For instance, in India, the popularity of home-diagnostic tests is surging, particularly for conditions like Type II diabetes where early detection can prevent complications such as heart failure. Similarly, early cancer screenings, like HPV tests for cervical cancer and routine checks for breast cancer, have significantly improved survival rates. These preventive measures not only lead to better health outcomes but also reduce the economic burden by minimizing the need for extensive treatments and hospitalizations.

Technological advancements are making preventive care more efficient and widespread. Artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy, enabling earlier detection of diseases such as heart conditions and Alzheimer’s. The FDA has recognized AI-based diagnostic tools for their precision in identifying cancer, which highlights their potential to improve healthcare delivery, especially in resource-limited environments. Additionally, healthcare organizations are increasingly leveraging vast data pools through predictive analytics, which utilizes ML and advanced analytics to extract insights that enhance operational efficiency and patient care. This approach helps in disease prevention and management, improving patient outcomes by predicting disease progression and facilitating early intervention. The Internet of Things (IoT) technology further augments this by allowing real-time monitoring of patient health, enabling timely medical interventions that prevent conditions from worsening, thus reducing hospital visits and enhancing overall patient outcomes.

Despite the benefits, the adoption of predictive diagnostics and early detection technologies faces challenges such as establishing demand, educating patients on the benefits, and securing financial and regulatory support for these innovations. To address these obstacles, healthcare organizations need to conduct thorough market research, form strategic partnerships, and invest in research and development. Protecting intellectual property and integrating new technologies into existing healthcare systems are also vital for expanding the scope of preventive healthcare. The broader adoption of predictive diagnostics heralds a major transformation in healthcare, focusing on prevention and early intervention. This approach not only aims to reduce healthcare costs but also enhances the quality of life, setting a foundation for a resilient future in global healthcare systems.

Select Competitors (Total 47 Featured) -

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN N.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Predictive Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in AI and Machine Learning Propel Growth in Predictive Diagnostics
    • Increasing Healthcare Data Availability Expands Addressable Market Opportunity
    • Rising Incidence of Chronic Diseases Throws the Spotlight on Predictive Diagnostics
    • Growing Emphasis on Preventive Healthcare Generates Demand for Predictive Solutions
    • Integration with Electronic Health Records (EHR) Spurs Adoption
    • Personalized Medicine Trends Sustain Growth in Predictive Diagnostic Tools
    • Big Data Analytics Advances Propel Growth in Predictive Healthcare Solutions
    • Cloud Computing Innovations Expand Addressable Market for Predictive Diagnostics
    • Improved Patient Outcomes through Early Detection Strengthens Business Case for Predictive Diagnostics
    • AI-driven Predictive Models Generate Demand for Advanced Diagnostic Tools
    • Real-time Monitoring and Predictive Analytics Propel Growth in Patient Care Management
    • Innovations in Biomarker Discovery Generate Opportunities for Predictive Diagnostics
    • Integration with IoT Devices in Healthcare Propels Growth of Predictive Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Predictive Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Rest of Europe Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Asia-Pacific Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF WORLD
    • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of World Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION